FDA Grants Full Approval to Pfizer COVID Vaccine for Ages 12-15

Published on July 8, 2022

The U.S. Food and Drug Administration said on Friday it has granted full approval to Pfizer and BioNTech’s COVID-19 vaccine for adolescents aged between 12 and 15 years. The vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency use…

Read Full Article (External Site)